Genome Canada has issued a press release to emphasize Canada's past and future role in the development of genomics, following the historic completion this week of a rough draft of the human genome.
The statement acknowledged the contributions of Canadian researchers - Drs Lap-Chee Tsui, Stephen Scherer, Bartha Maria Knoppers, and Charles Scriver - in the international effort, but stressed that the work in genomics is only just beginning.
The release was also the first acknowledgement that Dr Henry Friesen, former president of the Medical Research Council (MRC), has accepted the position of chair of Genome Canada's board of directors. It also marks the move of Marc Lepage to Genome Canada as VP corporate development. He was previously the MRC's director of business development.
R$